Cargando…
Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
Dihydropyrimidinase (DHP) is the second enzyme in the catabolic pathway of uracil, thymine, and chemotherapeutic fluoropyrimidine agents such as 5-fluorouracil (5-FU). Thus, DHP deficiency might be associated with 5-FU toxicity during fluoropyrimidine chemotherapy. We performed genetic analyses of t...
Autores principales: | Hiratsuka, Masahiro, Yamashita, Hiroshi, Akai, Fumika, Hosono, Hiroki, Hishinuma, Eiji, Hirasawa, Noriyasu, Mori, Takahiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4411063/ https://www.ncbi.nlm.nih.gov/pubmed/25915935 http://dx.doi.org/10.1371/journal.pone.0124818 |
Ejemplares similares
-
Expression of Concern: Genetic Polymorphisms of Dihydropyrimidinase in a Japanese Patient with Capecitabine-Induced Toxicity
Publicado: (2023) -
In Vitro Assessment of Fluoropyrimidine-Metabolizing Enzymes: Dihydropyrimidine Dehydrogenase, Dihydropyrimidinase, and β-Ureidopropionase
por: Hishinuma, Eiji, et al.
Publicado: (2020) -
Importance of Rare DPYD Genetic Polymorphisms for 5-Fluorouracil Therapy in the Japanese Population
por: Hishinuma, Eiji, et al.
Publicado: (2022) -
Heterologous expression of high-activity cytochrome P450 in mammalian cells
por: Kumondai, Masaki, et al.
Publicado: (2020) -
Functional Assessment of 12 Rare Allelic CYP2C9 Variants Identified in a Population of 4773 Japanese Individuals
por: Kumondai, Masaki, et al.
Publicado: (2021)